Reactions Weekly

, Volume 1723, Issue 1, pp 7–7 | Cite as

Baclofen for alcohol-use disorders: hospitalisation or death

Clinical study


  1. Chaignot C, et al. Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France. Pharmacoepidemiology and Drug Safety : 25 Sep 2018. Available from: URL:

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations